Stock exchange news | Navamedic

Read the latest news directly from the market.

Navamedic ASA: Annual Report for 2022

The report is attached to this notice and is available at navamedic.com/investors. In addition, the company has published its annual Read more

Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB

Navamedic ASA ("Navamedic") has today amended its Offer to SEK 8.00 per share in Sensidose AB ("Sensidose") representing a total Read more

Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million

Sensidose is a Sweden-based pharmaceutical company that sells drugs in combination with an innovative device for individual dosing, targeting patients Read more

Navamedic ASA: Q4 2022 financial results

“The fourth quarter completed an eventful year for Navamedic. Product launches, increased campaign activities and M&A agreements can summarise the Read more

Navamedic ASA: Invitation to 2022 4th quarter presentation

Oslo, February 13, 2023 - Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2022 results on Thursday February Read more

Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region

Clindamycin is a well-established antibiotic used in treatment of severe infections, including staphylococcal bone and joint infections, chronic sinusitis and Read more

Navamedic ASA: Q3 2022 financial results

“Looking back at another successful quarter, I am pleased to see that our strategic efforts to strengthen the existing business Read more

Navamedic ASA: Invitation to 2022 third quarter presentation

Oslo, October 25, 2022 - Navamedic ASA (OSE: Nava) will be presenting its third quarter 2022 results on Tuesday November Read more

Subscribe to stock exhange news